NASDAQ: DRIO - DarioHealth Corp.

Rentabilität für sechs Monate: -16.15%
Dividendenrendite: 0.00%
Sektor: Healthcare

Aktionsplan DarioHealth Corp.

Erweiterter Zeitplan Einfaches Diagramm
Financial Markets by TradingView

Über das Unternehmen DarioHealth Corp.

DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Move, which helps to prevent and treat the most common MSK conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; Dario One, a full suite of chronic condition management solutions; DarioEngage platform; and Dario blood glucose monitoring system.

weitere details
It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and Dario smart diabetes management solutions, including live clinical coaching, content, automated journeys, hardware, and lifestyle coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
Zur Vergleichsliste hinzufügen
Auf die Beobachtungsliste
Zum Portfolio hinzufügen
Preishinweis hinzufügen

IPO date 2014-10-06
ISIN US23725P2092
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.dariohealth.com
Цена ао 0.6901
Preisänderung pro Tag: +2.34% (0.68)
Preisänderung pro Woche: +0.8551% (0.69)
Preisänderung pro Monat: +6.21% (0.6552)
Preisänderung über 3 Monate: -11.8% (0.789)
Preisänderung über sechs Monate: -16.15% (0.8299)
Preisänderung pro Jahr: -65.12% (1.995)
Preisänderung über 3 Jahre: -90.47% (7.3)
Preisänderung über 5 Jahre: -90.93% (7.67)
Preisänderung über 10 Jahre: +0% (0.6959)
Preisänderung seit Jahresbeginn: +0.1295% (0.695)
Alle Parameter

Unterschätzung

Name Bedeutung Grad
P/S 2.33 6
P/BV 0.8149 9
P/E 0 0
EV/EBITDA -0.7835 0
Gesamt: 5.63

Effizienz

Name Bedeutung Grad
ROA, % -56.92 0
ROE, % -94.35 0
Gesamt: 0

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0 0
Gesamt: 0

Pflicht

Name Bedeutung Grad
Debt/EBITDA -0.5637 10
Gesamt: 8

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 167.79 10
Rentabilität Ebitda, % 210.73 10
Rentabilität EPS, % -73.28 0
Gesamt: 7.8
Weitere Details

Institutionen Volumen Aktie, %
Nantahala Capital Management, LLC 4673506 15.87
Appian Way Asset Management LP 1322444 4.49
Y.D. More Investments Ltd 1288518 4.38
Phoenix Holdings Ltd. 1180813 4.01
Clal Insurance Enterprises Holdings Ltd 875964 2.98
Vanguard Group Inc 363042 1.23
Geode Capital Management, LLC 270573 0.92
Clarity Capital Partners LLC 170426 0.58
Blackrock Inc. 112619 0.38
LPL Financial LLC 109901 0.37

ETF Aktie, % Rentabilität für das Jahr, % Dividenden, %
iShares Micro-Cap ETF 0.00664 17.09 1.54048



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. Erez Raphael CEO & Director 722.19k 1973 (52 Jahr)
Dov Oppenheim Co-Founder & Production Chief N/A
Josh Fischer Senior Vice President of Operations & Compliance N/A
Claudia Levi Content & Communications Manager N/A
Mr. Jean Christophe Muyl Head of Commercialization North America N/A
Mr. Tomer Ben-Kiki Chief Technology Officer N/A 1971 (54 Jahr)
Limor Drezner Chief People Officer N/A
Mr. Zvi Ben David CPA CFO, Treasurer & Secretary 342.58k 1961 (64 Jahr)
Kat Parrella Investor Relations Manager
Ms. Mona Dean Chief Compliance Officer

Adresse: United States, New York. NY, 18 West 18th Street - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.dariohealth.com